title: [Risk of cardiovascular complications cut in half?].
authors.affiliation: , .
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002318:Cardiovascular Diseases / Q000097:blood* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D006937:Hypercholesterolemia / Q000097:blood* / Q000188:drug therapy*; D008134:Long-Term Care; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D012697:Serine Endopeptidases
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D008078:Cholesterol, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases; C577155:evolocumab; C571059:alirocumab